Search Results - "Elorz, Mariana"

The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial by Marin-Alejandre, Bertha Araceli, Abete, Itziar, Cantero, Irene, Monreal, J Ignacio, Elorz, Mariana, Herrero, José Ignacio, Benito-Boillos, Alberto, Quiroga, Jorge, Martinez-Echeverria, Ana, Uriz-Otano, Juan Isidro, Huarte-Muniesa, María Pilar, Tur, Josep A, Martinez, J Alfredo, Zulet, M Angeles

“…The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing worldwide. NAFLD management is mainly focused on weight loss, but the optimal…”
Get full text

Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study by Galarregui, Cristina, Cantero, Irene, Marin-Alejandre, Bertha Araceli, Monreal, J. Ignacio, Elorz, Mariana, Benito-Boillos, Alberto, Herrero, José Ignacio, de la O, Víctor, Ruiz-Canela, Miguel, Hermsdorff, Helen Hermana M., Bressan, Josefina, Tur, Josep A., Martínez, J. Alfredo, Zulet, M. Angeles, Abete, Itziar

“…Purpose Identification of dietary factors involved in the development and progression of nonalcoholic fatty liver disease (NAFLD) is relevant to the current…”
Get full text

Interplay of Glycemic Index, Glycemic Load, and Dietary Antioxidant Capacity with Insulin Resistance in Subjects with a Cardiometabolic Risk Profile by Galarregui, Cristina, Zulet, María Ángeles, Cantero, Irene, Marín-Alejandre, Bertha Araceli, Monreal, José Ignacio, Elorz, Mariana, Benito-Boillos, Alberto, Herrero, José Ignacio, Tur, Josep Antoni, Abete, Itziar, Martínez, José Alfredo

“…Dietary total antioxidant capacity (TAC), glycemic index (GI), and glycemic load (GL) are accepted indicators of diet quality, which have an effect on…”
Get full text

Multipanel Approach including miRNAs, Inflammatory Markers, and Depressive Symptoms for Metabolic Dysfunction-Associated Steatotic Liver Disease Diagnosis during 2-Year Nutritional Intervention by Tobaruela-Resola, Ana Luz, Riezu-Boj, José I, Milagro, Fermin I, Mogna-Pelaez, Paola, Herrero, José I, Elorz, Mariana, Benito-Boillos, Alberto, Tur, Josep A, Martínez, J Alfredo, Abete, Itziar, Zulet, M Angeles

“…Metabolic dysfunction-associated steatotic liver disease (MASLD), with a prevalence of 30% of adults globally, is considered a multifactorial disease. There is…”
Get full text

Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study by Perez-Diaz-del-Campo, Nuria, Marin-Alejandre, Bertha Araceli, Cantero, Irene, Monreal, J. Ignacio, Elorz, Mariana, Herrero, José Ignacio, Benito-Boillos, Alberto, Riezu-Boj, Jose I., Milagro, Fermín I., Tur, Josep A., Martinez, J. Alfredo, Abete, Itziar, Zulet, M. Angeles

“…Purpose Non-alcoholic fatty liver disease (NAFLD) is worldwide recognized as the most common cause of chronic liver disease. Current NAFLD clinical management…”
Get full text

Association between Sleep Disturbances and Liver Status in Obese Subjects with Nonalcoholic Fatty Liver Disease: A Comparison with Healthy Controls by Marin-Alejandre, Bertha Araceli, Abete, Itziar, Cantero, Irene, Riezu-Boj, Jose I, Milagro, Fermín I, Monreal, J Ignacio, Elorz, Mariana, Herrero, José Ignacio, Benito-Boillos, Alberto, Quiroga, Jorge, Martinez-Echeverria, Ana, Uriz-Otano, Juan Isidro, Huarte-Muniesa, María Pilar, Tur, Josep A, Martínez, J Alfredo, Zulet, M Angeles

“…The relevance of sleep patterns in the onset or evolution of nonalcoholic fatty liver disease (NAFLD) is still poorly understood. Our aim was to investigate…”
Get full text

Isoliquiritigenin in combination with visceral adipose tissue and related markers as a predictive tool for nonalcoholic fatty liver disease by Mogna-Peláez, Paola, Romo-Hualde, Ana, Riezu-Boj, José I., Milagro, Fermin I., Muñoz-Prieto, David, Herrero, José I., Elorz, Mariana, Benito-Boillos, Alberto, Monreal, J. Ignacio, Tur, Josep A., Martínez, Alfredo, Abete, Itziar, Zulet, M. Angeles

“…Nonalcoholic fatty liver disease (NAFLD) is the most prevalent form of chronic liver disease in the world. New non-invasive diagnostic tools are needed to…”
Get full text

Neck Circumference for NAFLD Assessment during a 2-Year Nutritional Intervention: The FLiO Study by Elorz, Mariana, Benito-Boilos, Alberto, Marin, Bertha Araceli, Pérez Díaz Del Campo, Nuria, Herrero, Jose Ignacio, Monreal, Jose Ignacio, Tur, Josep A, Martínez, J Alfredo, Zulet, Maria Angeles, Abete, Itziar

“…Neck circumference (NC) and its relationship to height (NHtR) and weight (NWtR) appear to be good candidates for the non-invasive management of non-alcoholic…”
Get full text

Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study by Recaredo, Gregorio, Marin-Alejandre, Bertha Araceli, Cantero, Irene, Monreal, J Ignacio, Herrero, José Ignacio, Benito-Boillos, Alberto, Elorz, Mariana, Tur, Josep A, Martínez, J Alfredo, Zulet, M Angeles, Abete, Itziar

“…Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome. Obesity and unhealthy dietary habits are described as…”
Get full text

Association of the SH2B1 rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with Obesity and Non-Alcoholic Fatty Liver Disease by Perez-Diaz-Del-Campo, Nuria, Abete, Itziar, Cantero, Irene, Marin-Alejandre, Bertha Araceli, Monreal, J Ignacio, Elorz, Mariana, Herrero, José Ignacio, Benito-Boillos, Alberto, Riezu-Boj, Jose I, Milagro, Fermín I, Tur, Josep A, Martinez, J Alfredo, Zulet, M Angeles

“…Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide. Some genetic variants might be involved in the progression of this…”
Get full text

Three Different Genetic Risk Scores Based on Fatty Liver Index, Magnetic Resonance Imaging and Lipidomic for a Nutrigenetic Personalized Management of NAFLD: The Fatty Liver in Obesity Study by Perez-Diaz-Del-Campo, Nuria, Riezu-Boj, Jose I, Marin-Alejandre, Bertha Araceli, Monreal, J Ignacio, Elorz, Mariana, Herrero, José Ignacio, Benito-Boillos, Alberto, Milagro, Fermín I, Tur, Josep A, Abete, Itziar, Zulet, M Angeles, Martinez, J Alfredo

“…Non-alcoholic fatty liver disease (NAFLD) affects 25% of the global population. The pathogenesis of NAFLD is complex; available data reveal that genetics and…”
Get full text

Predictive Value of Serum Ferritin in Combination with Alanine Aminotransferase and Glucose Levels for Noninvasive Assessment of NAFLD: Fatty Liver in Obesity (FLiO) Study by Galarregui, Cristina, Marin-Alejandre, Bertha Araceli, Perez-Diaz-Del-Campo, Nuria, Cantero, Irene, Monreal, J. Ignacio, Elorz, Mariana, Benito-Boillos, Alberto, Herrero, José Ignacio, Tur, Josep A., Martínez, J. Alfredo, Zulet, M. Angeles, Abete, Itziar

“…The identification of affordable noninvasive biomarkers for the diagnosis and characterization of nonalcoholic fatty liver disease (NAFLD) is a major challenge…”
Get full text

Iatrogenic Hepatic Puncture while Placing a Peritoneal Drain: Percutaneous Direct Embolization under Ultrasound Guidance by Benito, Alberto, MD, PhD, Saiz-Mendiguren, Ramón, MD, García-Lallana, Amaia, MD, Cano, David, MD, Elorz, Mariana, MD, Bilbao, José Ignacio, MD, PhD

Get full text

Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial by Mogna-Peláez, Paola, Riezu-Boj, José I., Milagro, Fermin I., Herrero, José I., Elorz, Mariana, Benito-Boillos, Alberto, Tobaruela-Resola, Ana Luz, Tur, Josep A., Martínez, J Alfredo, Abete, Itziar, Zulet, M. Angeles

“…Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing public health concern. The disease is silent, and its diagnosis is often delayed…”
Get full text

Circulating microRNA panels in subjects with metabolic dysfunction-associated steatotic liver disease after following a 2-year dietary intervention by Tobaruela-Resola, Ana Luz, Riezu-Boj, José Ignacio, Milagro, Fermín I., Mogna-Pelaez, Paola, Herrero, José I., Elorz, Mariana, Benito-Boillos, Alberto, Tur, Josep A., Martínez, J. Alfredo, Abete, Itziar, Zulet, María Ángeles

“…Abstract Purpose Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) affects one-third of the global population. Despite its high prevalence,…”
Get full text

Effects of two personalized dietary strategies during a 2‐year intervention in subjects with nonalcoholic fatty liver disease: A randomized trial by Marin‐Alejandre, Bertha A., Cantero, Irene, Perez‐Diaz‐del‐Campo, Nuria, Monreal, Jose I., Elorz, Mariana, Herrero, Jose I., Benito‐Boillos, Alberto, Quiroga, Jorge, Martinez‐Echeverria, Ana, Uriz‐Otano, Juan I., Huarte‐Muniesa, Maria P., Tur, Josep A., Martinez, Jose A., Abete, Itziar, Zulet, Maria A.

“…Background and objectives Nonalcoholic fatty liver disease (NAFLD) management is focused on lifestyle modifications, but long‐term maintenance is a challenge…”
Get full text

The utility of ADC value in diffusion-weighted whole-body MRI in the follow-up of patients with multiple myeloma. Correlation study with 18F-FDG PET-CT by Paternain, Alberto, García-Velloso, María José, Rosales, Juan José, Ezponda, Ana, Soriano, Ignacio, Elorz, Mariana, Rodríguez-Otero, Paula, Aquerreta, Jesús Dámaso

“…•ADC and SUVmax have a strong, negative and significant correlation.•Bone lesions from responding patients have a significant increase in their mean ADC and a…”
Get full text

Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessment by Tobaruela-Resola, Ana Luz, Milagro, Fermín I, Elorz, Mariana, Benito-Boillos, Alberto, Herrero, José I, Mogna-Peláez, Paola, Tur, Josep A, Martínez, J Alfredo, Abete, Itziar, Zulet, M Ángeles

“…Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a worldwide leading cause of liver-related associated morbidities and mortality. Currently,…”
Get full text

Association between diet quality indicators and nonalcoholic fatty liver disease: The FLiO study by Galarregui, Cristina, Angeles Zulet, M., Marin-Alejandre, Bertha Araceli, Cantero, Irene, Goodwin, Nora, Ignacio Monreal, J., Elorz, Mariana, Benito-Boillos, Alberto, Tur, Josep A., Alfredo Martínez, J., Abete, Itziar

“…Abstract Introduction Dietary components are contributing factors in the development of Nonalcoholic fatty liver disease (NAFLD). The glycaemic index (GI),…”
Get full text

Depressive symptoms and liver fat in subjects with nonalcoholic fatty liver disease after 6-month weight loss intervention: The FLiO study by Marin-Alejandre, Bertha Araceli, Abete, Itziar, Cantero, Irene, Galarregui, Cristina, Elorz, Mariana, Tur, Josep A., Alfredo Martinez, J., Angeles Zulet, M.

“…Abstract Introduction: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in Western countries and is strongly associated with…”
Get full text